Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease

Annals of Oncology

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Devizzi, L ^a   Maffioli, L ^a   Bonfante, V ^a   Viviani, S ^a   Balzarini, L ^a   Gasparini, M ^a   Valagussa, P ^a   Bombardieri, E ^a   Santoro, A ^a   Bonadonna, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

computed tomography; gallium scan; magnetic resonance; mediastinal Hodgkin's disease

Indexed keywords

GALLIUM 67;

ADULT; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MEDIASTINUM CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THORAX SCINTISCANNING;

EID: 8244233157     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_1.S53     Document Type: Conference Paper

References (19)

1. Edwards CL, Hayes RL. Tumor scanning with Ga-67-67 citrate. J Nucl Med 1969; 10: 103-5.
2. Hagemeister FB, Fesus SM, Lamki M et al. Role of the Ga-67 scan in Hodgkin's disease. Cancer 1990; 65: 1090-6.
3. Brun B, Laursen K, Soresen IN et al. CT in retroperitoneal fibrosis. Am J Roentgenol 1981; 137: 535-40.
4. Lewis E, Bernerdino ME, Salvadoer PG et al. Post therapy CT detected mass in lymphoma patients: It is viable tissue? J Comput Assist Tomogr 1982; 6: 792-6.
5. Stolar CJH, Garvin JH, Rustad DG et al. Residual or recurrent chest mass in pediatric Hodgkin's disease: A surgical problem? Am J Pediatr Hematol Oncol 1987; 9: 289-94.
6. Jochelson M, Mauch P, Bilikian J et al. The significance of the residual mediastinal mass in treated Hodgkin's disease. J Clin Oncol 1985; 3: 637-40.
7. Israel O, Front D, Epelbaum R et al. Residual mass and negative Ga-67 scintigraphy in treated lymphoma. J Nucl Med 1990; 31: 365-8.
8. Nyman RS, Rehn SM, Glimelius BL et al. Residual mediastinal masses in Hodgkin's disease: Prediction of size with MR imaging. Radiology 1989; 170: 435-40.
9. Glazer SH, Lee JKT, Levitt RG et al. Radiation fibrosis: Differentiation from recurrent tumor by MR imaging. Radiology 1985; 156: 721-6.
10. Santoro A, Bonfante V, Viviani S et al. Subtotal nodal (STNI) vs. involved field (IF) irradiation after 4 cycles of ABVD in early stage Hodgkin's disease (HD). Proc Am Soc Clin Oncol 1996; 15: 415 (Abstr 1270).
11. Viviani S, Santoro A, Devizzi L et al. VEBEP plus involved-field RT: Efficacy and feasibility of an intensive regimen for advanced Hodgkin's disease (HD). Proc Am Soc Clin Oncol 1996; 14: 395 (Abstr 1234).
12. Johnston GS, Go MF, Benna RS et al. Ga-67-67 citrate imaging in Hodgkin's disease: Final report of cooperative group. J Nucl Med 1977; 18: 692-8.
13. King DJ, Dawson AA, McDonald AV et al. Ga-67 scanning in lymphoma. Clin Radiol 1980; 31: 729-32.
14. Anderson KC, Leonard RCF, Canellos GP et al. High dose Ga-67 imaging in lymphoma. Am J Med 1983; 75: 327-31.
15. Israel O, Front D, Lam M et al. Ga-67-67 imaging in monitoring lymphoma response to treatment. Cancer 1988; 61: 2439-41.
16. Canellos GP. Residual mass in lymphoma may not be residual disease (editorial). J Clin Oncol 1988; 7: 931-2.
17. Karimjee S, Brada M, Husband J et al. A comparison of Ga-67-67 single photon emission computed tomography in mediastinal Hodgkin's disease. Eur J Cancer 1992; 11: 1856-7.
18. Gasparini M, Balzarini L, Castellani MR et al. Current role of Ga67 scan and magnetic resonance imaging in the management of mediastinal Hodgkin's lymphoma. Cancer 1993; 72: 577-82.
19. Foss Abrahamsen A, Lien HH, Aas M et al. Magnetic resonance imaging and 67 GA-67 scan in mediastinal malignant lymphoma: A prospective study. Ann Oncol 1994; 5: 433-6.